Ron James
Direktor/Vorstandsmitglied bei Haemostatix Ltd.
Profil
Ron James is currently a Non-Executive Director at Haemostatix Ltd.
and Parkure Ltd.
He was previously the Chairman of Aquapharm Biodiscovery Ltd.
and the Managing Director of PPL Therapeutics Plc.
Dr. James obtained his undergraduate degree from the University of London in 2001.
Aktive Positionen von Ron James
Unternehmen | Position | Beginn |
---|---|---|
Haemostatix Ltd.
Haemostatix Ltd. Pharmaceuticals: MajorHealth Technology Haemostatix Ltd. designs and develops solutions for haemostasis and thrombosis. Its products include Rapid and effective haemostatic action which is new class of topical coagulant or haemostat that is applied directly to a wound during surgery to control bleeding, and ready-to-use formulations, blood-free ingredients and a new class with a unique mode of action. The company was founded by Sarah Middleton and Alison Goodall in 2003 and is headquartered in Nottingham, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Parkure Ltd.
Parkure Ltd. Pharmaceuticals: MajorHealth Technology Parkure Ltd. develops and discovers drugs for cure of parkinson's disease . The company was founded by Lysimachos Zografos and is headquartered in Lanarkshire, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ron James
Unternehmen | Position | Ende |
---|---|---|
PPL Therapeutics Plc
PPL Therapeutics Plc Pharmaceuticals: MajorHealth Technology PPL Therapeutics Plc produces commercially valuable proteins. It is a multinational corporation operating in the field of recombinant proteins using transgenic technology. The company does business in the pharmaceutical, biotechnology and nutraceutical industries. PPL is headquartered in Edinburgh, UK. | Corporate Officer/Principal | - |
Aquapharm Biodiscovery Ltd.
Aquapharm Biodiscovery Ltd. Pharmaceuticals: MajorHealth Technology Aquapharm Biodiscovery Ltd. discovers and develops drugs. It develops products for application across the pharmaceutical, personal care and nutrition sectors. The company offers antibiotics, inflammation & dermatology, oxidative stress, high value ingredients and anti-oxidant ingredients. Aquapharm Biodiscovery was founded by Kathryn Fraser and Andrew Mearns Spragg on April 11, 2000 and is headquartered in Edinburgh, GB. | Vorsitzender | - |
Ausbildung von Ron James
University of London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
PPL Therapeutics Plc
PPL Therapeutics Plc Pharmaceuticals: MajorHealth Technology PPL Therapeutics Plc produces commercially valuable proteins. It is a multinational corporation operating in the field of recombinant proteins using transgenic technology. The company does business in the pharmaceutical, biotechnology and nutraceutical industries. PPL is headquartered in Edinburgh, UK. | Health Technology |
Aquapharm Biodiscovery Ltd.
Aquapharm Biodiscovery Ltd. Pharmaceuticals: MajorHealth Technology Aquapharm Biodiscovery Ltd. discovers and develops drugs. It develops products for application across the pharmaceutical, personal care and nutrition sectors. The company offers antibiotics, inflammation & dermatology, oxidative stress, high value ingredients and anti-oxidant ingredients. Aquapharm Biodiscovery was founded by Kathryn Fraser and Andrew Mearns Spragg on April 11, 2000 and is headquartered in Edinburgh, GB. | Health Technology |
Haemostatix Ltd.
Haemostatix Ltd. Pharmaceuticals: MajorHealth Technology Haemostatix Ltd. designs and develops solutions for haemostasis and thrombosis. Its products include Rapid and effective haemostatic action which is new class of topical coagulant or haemostat that is applied directly to a wound during surgery to control bleeding, and ready-to-use formulations, blood-free ingredients and a new class with a unique mode of action. The company was founded by Sarah Middleton and Alison Goodall in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
Parkure Ltd.
Parkure Ltd. Pharmaceuticals: MajorHealth Technology Parkure Ltd. develops and discovers drugs for cure of parkinson's disease . The company was founded by Lysimachos Zografos and is headquartered in Lanarkshire, the United Kingdom. | Health Technology |